
Find out more about the latest breakthrough from researchers across Europe on the significance of ALK gene alterations in high-risk neuroblastoma.

In the latest edition of her blog our CEO, Gail, shares her experience of being part of the National Neuroblastoma Nursing Group, made up of cancer nurse specialists and research nurses.

In 2018, we announced our awarded membership to the Association of Medical Research Charities (AMRC), but what does this actually mean for our research?

The Spring months have been as busy as ever for our research team, with the announcement of our latest project as well as progress reviews for our ongoing work and looking ahead at the SKC research strategy for the coming years.

Solving Kids' Cancer patron Rob Brydon shares a special message about the Butterfly Relay

Solving Kids’ Cancer UK with partners have awarded £500,000 to the Children’s Hospital of Philadelphia (CHOP) and collaborating institutions for research into identifying and treating neuroblastoma in newly diagnosed children.

A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults.

In the latest edition of her blog our CEO, Gail, reflects on what it means to be part of a parent-led charity.

We had We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients.